Savill Corrine

Savill Corrine is listed in filings as Chief Business Officer at Cullinan Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 19, 2026, including 3 public disclosures. Recent filings connect the profile to Cullinan Therapeutics, Inc. (CGEM). The current snapshot covers public activity from Feb 21, 2025 to Feb 19, 2026. Reported amounts are shown as $707.3K to $2.2M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.